MEN1 and multiple endocrine neoplasia type 1: However, loss‐of‐function mutations in Menin lead to multiple endocrine neoplasia type I,43, 44 so it is important to ensure that small molecule inhibitors of the MLL1–Menin protein–protein interaction do not globally affect Menin activity.